Contents

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Volume 3 - Number 2

Update on Current and Future Pharmacologic Therapy of COPD

, 3(2): 81 - 101

L. Brandolini, M. Allegretti, S. Colagioia, R. Novellini, F. Colotta, R. Bertini and G. Melillo


DOI: 10.2174/1568014043355429




Chemokines and Persistent Inflammation in Rheumatoid Arthritis: Hunting for Therapeutic Targets

, 3(2): 103 - 117

A. D. Filer, A. C. Burman, O. Haworth, G. Parsonage, M. Salmon and C. D. Buckley


DOI: 10.2174/1568014043355393




Recent Advances for Cell / Gene Therapy in Rheumatoid Arthritis

, 3(2): 119 - 138

F. Apparailly, P. Plence, D. Noel and C. Jorgensen


DOI: 10.2174/1568014043355410




Quantitative Structure Activity Relationships (QSARs) on Lipoxygenase Inhibitors

, 3(2): 139 - 156

Eleni Pontiki and Dimitra Hadjipavlou-Litina


DOI: 10.2174/1568014043355375




Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications

, 3(2): 157 - 165

L. Mastalerz, M. Sanak and A. Szczeklik


DOI: 10.2174/1568014043355384




The Basophil Granulocyte in Allergic Reactions: Experimental Models and their Use for the Identification of Drugs with Effects or Side Effects on Basophils

, 3(2): 167 - 180

Lars K. Poulsen, Sha Quan, Claudia Krag, Michael H. Platzer and Per Stahl Skov


DOI: 10.2174/1568014043355401




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science